首页--工业技术论文--化学工业论文--制药化学工业论文--有机化合物药物的生产论文

苯并噻嗪类醛糖还原酶抑制剂的立体选择性合成

摘要第6-8页
ABSTRACT第8-9页
LIST OF ABBREVIATIONS第11-15页
CHAPTER 1第15-34页
    INTRODUCTION第15页
    1.1 DIABETES MELLITUS第15-17页
    1.2 MECHANISM OF ACTION OF ALDOSE REDUCTASE AND DIABETIC COMPLICATIONS第17-22页
        1.2.1 POLYOL PATHWAY第17-18页
        1.2.2 DIABETIC RETINOPATHY第18页
        1.2.3 DIABETIC NEUROPATHY第18-19页
        1.2.4 DIABETIC NEPHROPATHY第19页
        1.2.5 STRUCTURE AND PROPERTIES OF ALDOSE REDUCTASE (AR)第19-22页
    1.3 ALDOSE REDUCTASE INHIBITORS第22-28页
        1.3.1 CARBOXYLIC ACID ARIS第23-25页
        1.3.2 CYCLIC AMIDE ARIS第25-26页
        1.3.3 SULPHONYL GROUP CONTAINING ARIS第26-27页
        1.3.4 MISCELLANEOUS ARIS第27-28页
    1.4 BIOLOGICAL ACTIVITIES OF 1,2-BENZOTHIAZINE第28-31页
        1.4.1 ANALGESIC AND ANTI-INFLAMMATORY AGENTS第28-29页
        1.4.2 ANTI-OXIDANT AND ANTI-BACTERIAL ACTIVITIES第29-30页
        1.4.3 CALPAIN I INHIBITORS第30页
        1.4.4 1 , 2-BENZOTHIAZINE AS ALDOSE REDUCTASE INHIBITORS第30-31页
    1.5 SCOPE OF STUDY AND RESEARCH PLAN第31-34页
CHAPTER 2 REGIOSELECTIVE SYNTHESIS OF 1,2-BENZOTHIAZINE 1,1-DIOXIDE DERIVATIVES第34-53页
    2.1 INTRODUCTION第34-35页
    2.2 REGIOSELECTIVE SYNTHESIS OF OLEFINIC ISOMERS第35-39页
        2.2.1 SYNTHETIC ROUTE第35-36页
        2.2.2 OVERVIEW OF WITTIG OLEFINATION REACTION第36-37页
        2.2.3 STEREOSELECTIVITY OF WITTIG REACTION第37-39页
    2.3 RESULTS AND DISCUSSION第39-45页
        2.3.1 SYNTHESIS OF SUBSTRATES第39-40页
        2.3.2 THERMOCONTROLLED REGIOSELECTIVE SYNTHESIS第40-43页
        2.3.3 COMPOUND STRUCTURE AND STEREOCHEMISTRY第43-45页
    2.4 CONCLUSIONS第45页
    2.5 EXPERIMENTAL SECTION第45-53页
        2.5.1 SYNTHESIS AND CHARACTERIZATION OF COMPOUNDS 47-49第46-48页
        2.5.2 SYNTHESIS OF COMPOUNDS 50A,B第48-49页
        2.5.3 GENERAL SYNTHETIC PROCEDURE FOR 51-53 (A-B)第49-53页
CHAPTER 3 ASYMMETRIC 1,4-HYDROSILYLATION OF 1,2-BENZOTHIAZINE 1,1-DIOXIDE DERIVATIVES第53-74页
    3.1 INTRODUCTION第53-56页
        3.1.1 ASYMMETRIC HYDROGENATION第53-54页
        3.1.2 OVERVIEW OF ASYMMETRIC 1,4-HYDROSILYLATION第54-56页
    3.2 RESULTS AND DISCUSSION第56-61页
        3.2.1 SYNTHETIC ROUTE第56-57页
        3.2.2 COPPER CATALYZED 1,4-HYDROSILYLATION第57-61页
    3.3 CONCLUSION第61页
    3.4 EXPERIMENTAL SECTION第61-74页
        3.4.1 GENERAL SYNTHETIC PROCEDURE FOR 50A, 61-62第62-63页
        3.4.2 GENERAL SYNTHETIC PROCEDURE FOR 51A, 63-66第63-66页
        3.4.3 GENERAL METHOD FOR OLEFIN REDUCTION第66-69页
        3.4.4 GENERAL METHOD FOR ASYMMETRIC 1,4-REDUCTION第69-74页
CHAPTER 4 ASSESSMENT OF 1,2-BENZOTHIAZINE-1,1-DIOXIDE CARBOXYLATES DERIVATIVES AS ALDOSE REDUCTASE INHIBITORS第74-94页
    4.1 INTRODUCTION第74-75页
    4.2 SYNTHETIC ROUTE第75-76页
        4.2.1 STEREOISOMERS OF 1,2-BENZOTHIAZINE-1,1-DIOXIDE DERIVATIVES第75-76页
        4.2.2 ENANTIOMERS OF 1,2-BENZOTHIAZINE-1,1-DIOXIDE DERIVATIVES第76页
    4.3 RESULTS AND DISCUSSION第76-79页
        4.3.1 SAR STUDY OF STEREOISOMERS OF BENZOTHIAZINE DERIVATIVES第76-77页
        4.3.2 SAR STUDY OF CHIRAL BENZOTHIAZINE DERIVATIVES第77-79页
    4.4 CONCLUSION第79页
    4.5 EXPERIMENTAL SECTION第79-94页
        4.5.1 GENERAL METHOD FOR ACID HYDROLYSIS OF 51-53(A-B)第79-83页
        4.5.2 GENERAL METHOD FOR ACID HYDROLYSIS OF 63, 65-66第83-87页
        4.5.3 IN VITRO INHIBITION ACTIVITY EXPERIMENT第87-94页
CHAPTER 5 DOCKING STUDIES OF 1,2-BENZOTHIAZINE-1,1-DIOXIDE CARBOXYLATES WITH ALDOSE REDUCTASE第94-102页
    5.1 INTRODUCTION第94-95页
    5.2 MOLECULAR MODELING第95-96页
    5.3 RESULTS AND DISCUSSION第96-100页
        5.3.1 MOLCULAR DOCKING OF STEREOISOMERS OF BENZOTHIAZINE DERIVATIVES第97-100页
        5.3.2 MOLCULAR DOCKING OF ENANTIOMERS OF BENZOTHIAZINE DERIVATIVES84第100页
    5.4 CONCLUSION第100页
    5.5 EXPERIMENTAL SECTION第100-102页
SUMMARY第102-104页
SUGGESTIONS AND FUTURE STUDY第104-105页
REFERENCES第105-124页
APPENDIX第124-179页
LIST OF PUBLICATIONS第179-181页
ACKNOWLEDGEMENT第181-183页
ABOUT AUTHOR第183页

论文共183页,点击 下载论文
上一篇:慢病毒介导RNAi沉默Id1对肠癌HCT116细胞干细胞相关特性和侵袭转移的影响
下一篇:Fenton体系中聚2,3-二甲基苯胺及其复合物的制备、表征与构性关系研究